Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada

por Skowronski, Danuta M., Kaweski, Samantha E., Irvine, Michael A., Chuang, Erica S.Y., Kim, Shinhye, Sabaiduc, Suzana, Reyes, Romina C., Henry, Bonnie, Sekirov, Inna, Smolina, Kate
Publicado 2023

Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada

por Tanunliong, Guadalein, Liu, Aaron C., Kaweski, Samantha, Irvine, Mike, Reyes, Romina C., Purych, Dale, Krajden, Mel, Morshed, Muhammad, Sekirov, Inna, Gantt, Soren, Skowronski, Danuta M., Jassem, Agatha N.
Publicado 2022

Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada

por Kim, Shinhye, Chuang, Erica SY, Sabaiduc, Suzana, Olsha, Romy, Kaweski, Samantha E, Zelyas, Nathan, Gubbay, Jonathan B, Jassem, Agatha N, Charest, Hugues, De Serres, Gaston, Dickinson, James A, Skowronski, Danuta M
Publicado 2022

Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada

por Skowronski, Danuta M., Kaweski, Samantha E., Irvine, Michael A., Kim, Shinhye, Chuang, Erica S.Y., Sabaiduc, Suzana, Fraser, Mieke, Reyes, Romina C., Henry, Bonnie, Levett, Paul N., Petric, Martin, Krajden, Mel, Sekirov, Inna
Publicado 2022

Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23

por Skowronski, Danuta M, Chuang, Erica SY, Sabaiduc, Suzana, Kaweski, Samantha E, Kim, Shinhye, Dickinson, James A, Olsha, Romy, Gubbay, Jonathan B, Zelyas, Nathan, Charest, Hugues, Bastien, Nathalie, Jassem, Agatha N, De Serres, Gaston
Publicado 2023